TQY-12226-15144
2 vaccinations
3 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 596 / MT
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- DGW-67337-76348
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-24
Registered in v-safe
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-07
- 2022-07-14
-
2022-07-15
Dose 2 — Pfizer-BioNTech
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-29
- 2022-08-05
- 2022-08-12
-
2022-08-19
Survey response — day 35, dose 2, dependentMedDRA: Pyrexia, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: Fever, sneezing, nasal dischargeMedDRA releases: 2024-11 · check-in free text available
-
2022-08-26
Survey response — day 42, dose 2, dependentMedDRA: Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: Positive covid test on 8/14/22. Still positive on 8/23/22. Low grade fever on 8/17 and 8/18MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
-
2023-01-14
Survey response — 6 months, dose 2, dependentMedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-14
Report sent to call center — 6 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-16
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-07-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — day 35, dose 2, dependent
Symptoms: Fever, sneezing, nasal discharge
Release 12 — day 42, dose 2, dependent
Symptoms: Positive covid test on 8/14/22. Still positive on 8/23/22. Low grade fever on 8/17 and 8/18
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release